ArticleJournal of thrombosis and thrombolysis2022

Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage.

Stacy Pasciolla et al.PubMed ↗Publisher ↗

No numbers read from the abstract.